Cyclerion Therapeutics (CYCN) Net Cash Flow (QoQ) (2019 - 2025)
Cyclerion Therapeutics (CYCN) Net Cash Flow (QoQ) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Cyclerion Therapeutics |
11.50 Mn |
8.26 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
346.76% |
| Jun 30, 2025 |
-255.53% |
| Mar 31, 2025 |
13.06% |
| Dec 31, 2024 |
120.98% |
| Sep 30, 2024 |
-55.15% |
| Jun 30, 2024 |
40.89% |
| Mar 31, 2024 |
-21.41% |
| Dec 31, 2023 |
-144.45% |
| Sep 30, 2023 |
152.89% |
| Jun 30, 2023 |
-5.49% |
| Mar 31, 2023 |
11.62% |
| Dec 31, 2022 |
29.09% |
| Sep 30, 2022 |
8.20% |
| Jun 30, 2022 |
15.85% |
| Mar 31, 2022 |
-50.20% |
| Dec 31, 2021 |
-8.34% |
| Sep 30, 2021 |
-131.39% |
| Jun 30, 2021 |
293.76% |
| Mar 31, 2021 |
-4.18% |
| Dec 31, 2020 |
-234.96% |
